Announcements Trials
Browse Landscape

Phase

Phase NA 92Phase 3 5Phase 2 4Phase 4 3Phase 1/2 3Phase 2/3 1

Status

Withdrawn 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 3NETWORK 1

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 1889Carcinoma, Non-Small-Cell Lung 1350Prostatic Neoplasms 980Colorectal Neoplasms 851Multiple Myeloma 741Leukemia, Myeloid, Acute 725Neoplasms 691Lung Neoplasms 680Neoplasm Metastasis 642Lymphoma 579Carcinoma, Hepatocellular 571Pancreatic Neoplasms 567Stomach Neoplasms 523Leukemia 511Recurrence 493Leukemia, Lymphocytic, Chronic, B-Cell 459Precursor Cell Lymphoblastic Leukemia-Lymphoma 452Melanoma 451Lymphoma, Non-Hodgkin 443Ovarian Neoplasms 426Lymphoma, Large B-Cell, Diffuse 423Squamous Cell Carcinoma of Head and Neck 416Myelodysplastic Syndromes 416Head and Neck Neoplasms 404Brain Neoplasms 403Rectal Neoplasms 397Glioblastoma 375Carcinoma, Renal Cell 350Hodgkin Disease 338Esophageal Neoplasms 337

Interventions

siltuximab 1erenumab 1Standard of Care 1Saline Solution 1Pain Management 1Donepezil 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Chronic Pain × Clear all
NCT05684692 2026-04-23

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Massachusetts General Hospital

Phase 2 Recruiting
40 enrolled

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

NCT05877521 2025-09-23

Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
76 enrolled

Cancer Pain, Chronic Pain

NCT05254639 2024-04-05

DONEPEZOX

University Hospital, Clermont-Ferrand

Phase 2 Completed
77 enrolled

Chronic Pain

NCT01374191 2015-08-26

Botulinum Toxin Type A for Neuroma Pain

Southern Illinois University

Phase 2 Withdrawn

Neuroma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡